Supplementary Table 1 from A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas

Autor: George D. Demetri, David Grayzel, Emmanuel Normant, Joi Dunbar, Michael Gordon, Suzanne George, Jeffrey A. Morgan, Lee S. Rosen, Rashmi Chugh, Andrew J. Wagner
Rok vydání: 2023
DOI: 10.1158/1078-0432.22449941
Popis: Supplementary Table 1 - PDF file 74K, Mean (SD) pharmacokinetic parameters of IPI-504 and metabolites on Cycle 1, Day 1
Databáze: OpenAIRE